Literature DB >> 21183743

Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil.

Ellen Knierim1, Lilia Leisle, Christiane Wagner, Bernhard Weschke, Barbara Lucke, Georg Bohner, Jens P Dreier, Markus Schuelke.   

Abstract

BACKGROUND AND
PURPOSE: Familial hemiplegic migraine is characterized by recurrent migraine, hemiparesis, and ataxia. Causes may be mutations in calcium and sodium channels or in a subunit of the Na/K-ATPse. Migraine treatment with calcium channel blockers was only successful in some patients. Summary of Case- We describe a 6-year-old girl with recurrent ischemic strokes after minor head trauma associated with seizures, hemiparesis, fever, and altered consciousness. Genetic analysis revealed a spontaneous, novel dominant CACNA1A mutation (c.4046G→A, p.R1349Q) that removed a highly conserved arginine of the voltage sensing region of the P/Q-type Ca(v)2.1 channel. Because a homologous mutation in the tottering-5J mouse increased open probability of the channel as well as calcium influx, we treated the patient with the calcium channel blocker verapamil during characteristic prodromi after head trauma. Treatment was instantly effective and prevented a new stroke.
CONCLUSIONS: CACNA1A mutations should be considered in the diagnostic workup of childhood stroke, especially if associated with ataxia and migraine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183743     DOI: 10.1161/STROKEAHA.110.600023

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Exploitation of the spreading depolarization-induced cytotoxic edema for high-resolution, 3D mapping of its heterogeneous propagation paths.

Authors:  Jens P Dreier; Clemens Reiffurth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

Review 3.  Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases.

Authors:  Nasrin Nejatbakhsh; Zhong-ping Feng
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 4.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

Authors:  Jens P Dreier
Journal:  Nat Med       Date:  2011-04-07       Impact factor: 53.440

Review 5.  Dissecting the association between migraine and stroke.

Authors:  Andrea M Harriott; Kevin M Barrett
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

6.  Complex effects on CaV2.1 channel gating caused by a CACNA1A variant associated with a severe neurodevelopmental disorder.

Authors:  Benjamin J Grosso; Audra A Kramer; Sidharth Tyagi; Daniel F Bennett; Cynthia J Tifft; Precilla D'Souza; Michael F Wangler; Ellen F Macnamara; Ulises Meza; Roger A Bannister
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

7.  Two Children with Early-Onset Strokes and Intractable Epilepsy, Both with CACNA1A Mutations.

Authors:  Kristen N Bolte; Melissa Assaf; Tamara Zach; Shubhangi Peche
Journal:  Child Neurol Open       Date:  2022-04-27

8.  A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx.

Authors:  Maria Isabel Bahamonde; Selma Angèlica Serra; Oliver Drechsel; Rubayte Rahman; Anna Marcé-Grau; Marta Prieto; Stephan Ossowski; Alfons Macaya; José M Fernández-Fernández
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

9.  Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies.

Authors:  Oriel Carreño; Roser Corominas; Selma Angèlica Serra; Cèlia Sintas; Noèlia Fernández-Castillo; Marta Vila-Pueyo; Claudio Toma; Gemma G Gené; Roser Pons; Miguel Llaneza; María-Jesús Sobrido; Daniel Grinberg; Miguel Ángel Valverde; José Manuel Fernández-Fernández; Alfons Macaya; Bru Cormand
Journal:  Mol Genet Genomic Med       Date:  2013-07-02       Impact factor: 2.183

10.  Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.

Authors:  Mercè Izquierdo-Serra; Antonio F Martínez-Monseny; Laura López; Julia Carrillo-García; Albert Edo; Juan Darío Ortigoza-Escobar; Óscar García; Ramón Cancho-Candela; M Llanos Carrasco-Marina; Luis G Gutiérrez-Solana; Daniel Cuadras; Jordi Muchart; Raquel Montero; Rafael Artuch; Celia Pérez-Cerdá; Belén Pérez; Belén Pérez-Dueñas; Alfons Macaya; José M Fernández-Fernández; Mercedes Serrano
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.